Echo Therapeutics (ECTE) Reports Q2 Loss of $0.82/Share

August 12, 2016 2:45 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Echo Therapeutics (NASDAQ: ECTE) reported Q2 EPS of ($0.82), versus ($0.97) reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment